Combined orthotopic heart transplantation followed by autologous stem cell transplantation in a patient with light chain amyloidosis and isolated cardiac involvement

Abstract

Please cite this article as: V. M. Parato, et al., Combined orthotopic heart transplantation followed by autologous stem cell transplantation in a patient with light chain amyloidosis and isolated cardiac involvement, Cor et Vasa 60 (2018) e518-e521 as

Usefulness of Sacubitril/Valsartan in reduction of atrial fibrillation burden in a patient with ICD delivering inappropriate therapies. A new possibility?

“…Many conditions different from coronary artery disease leading to HF may have benefi t from advanced non-pharmacological therapy. 12,13 While the exact impact in different cardiac disorders 14,15 is currently under investigation and new interesting therapeutic perspectives are currently emerging, 16 it is clear that HF is more complex than believed. The use of cardiac devices poses problems deriving both from patients 17 and from the risk of infections 18 even if it is often necessary.…”